nephropathy

(redirected from Diabetic nephropathy)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Diabetic nephropathy: diabetic retinopathy, diabetic neuropathy

ne·phrop·a·thy

 (nə-frŏp′ə-thē)
n. pl. ne·phrop·a·thies
A disease or abnormality of the kidney.

neph′ro·path′ic (nĕf′rə-păth′ĭk) adj.

nephropathy

(nɛfˈrɒpəθɪ)
n
(Medicine) kidney disease or malfunction

ne•phrop•a•thy

(nəˈfrɒp ə θi)

n.
any disease of the kidney.
[1915–20]
neph•ro•path•ic (ˌnɛf rəˈpæθ ɪk) adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.nephropathy - a disease affecting the kidneys
Bright's disease, nephritis - an inflammation of the kidney
nephroangiosclerosis, nephrosclerosis - kidney disease that is usually associated with hypertension; sclerosis of the renal arterioles reduces blood flow that can lead to kidney failure and heart failure
PKD, polycystic kidney disease - kidney disease characterized by enlarged kidneys containing many cysts; often leads to kidney failure
polyuria - renal disorder characterized by the production of large volumes of pale dilute urine; often associated with diabetes
kidney failure, renal failure - inability of the kidneys to excrete wastes and to help maintain the electrolyte balance
renal insufficiency - insufficient excretion of wastes by the kidneys
uropathy - any pathology of the urinary tract
Translations

ne·phrop·a·thy

n. nefropatía, cualquier enfermedad del riñón.

nephropathy

n nefropatía; diabetic — nefropatía diabética
References in periodicals archive ?
Objective: To analyze the values of combined detection of urinary micro albumin (mAlb), [alpha]1-microglobulin ([alpha]1-MG) and N-acetyl-[beta]-D-glucosaminidase (NAG) in the early diagnosis of diabetic nephropathy (DN).
Diabetes is the major cause of end- stage renal disease and diabetic nephropathy which are also called as diabetic kidney disease.
Various novel biomarkers have been studied for earlier detection of diabetic nephropathy including glomerular dysfunction, tubular dys function and oxidative stress markers4.
The main growth drivers for the therapeutic pipeline of diabetic nephropathy are increasing investment in research and development of new drugs for the disease, rising prevalence of diabetes and obesity, elevated awareness about diabetes and kidney-related disorders.
Diabetic nephropathy is the leading cause of End Stage Renal Disease (ESRD) worldwide and a leading cause of DM-related morbidity and mortality.
The paper concluded that a single intravenous infusion of MPC-300-IV was well tolerated and had positive effects on renal function at the 12-week primary endpoint in a Phase 2 trial in adult patients with type 2 diabetic nephropathy.
com)-- The Diabetic Nephropathy pipeline Insight Reports provides client with details of Diabetic Nephropathy Pipeline products across the globe.
However, the protective effects of the pharmacological activity and potential mechanisms in diabetic nephropathy are still not known.
Objective: To evaluate the effects on filtration membrane of glomerulus after islet transplantation in a rat model of streptozotocin-induced diabetic nephropathy.
NephroGenex, a company that develops drugs to treat kidney disease, with a first indication in diabetic nephropathy, has announced that the independent Data and Safety Monitoring Board (DSMB) for the company's pivotal Phase three study of oral Pyridorin, has completed the second, pre-planned six-month safety review, it was reported on Friday.
Chen, "Chaperonin-containing t-complex protein-1 subunit [beta] as a possible biomarker for the phase of glomerular hyperfiltration of diabetic nephropathy," Disease Markers, vol.
It is also used for diabetic nephropathy treatment with an elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension.